1. Home
  2. SLRN

SLRN

ACELYRIN INC.

Logo ACELYRIN INC.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-24-2024 2:39pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Acelyrin Inc is a late-stage clinical biopharmaceutical company. It is focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating development and commercialization of of transformative medicines.

Founded: 2020 Country:
N/A
Employees: N/A City: AGOURA HILLS
Market Cap: 492.8M IPO Year: 2023
Target Price: $23.67 AVG Volume (30 days): 1.2M
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -5.43 EPS Growth: N/A
52 Week Low/High: $5.34 - $29.88 Next Earning Date: 01-01-0001
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks:

Stock Insider Trading Activity of ACELYRIN INC. (SLRN)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Lin Shao-Lee SLRN Chief Executive Officer Apr 1 '24 Sell $6.63 9,961 $66,024.50 1,577,374 SEC Form 4